FDA to schedule panel review for Abbott's Xience stent

09/11/2007 | Wall Street Journal, The

The FDA plans to schedule an advisory panel review for Abbott Laboratories' Xience drug-coated coronary stent, an Abbott executive said. The company, which hopes to introduce the device in the U.S. in the first half of 2008, said it's working with the agency to schedule the meeting "as expeditiously as possible."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA